An Open-Label Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients with Facioscapulohumeral Muscular Dystrophy (FSHD) Previously Enrolled in Stsudy A083-02 and in Patients with Charcot-Marie-Tooth (CMT) Disease Types 1 and X Previousl
|Effective start/end date||3/1/19 → 2/28/22|
- ACCELERON PHARMA INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.